The impact of chemo- and radiotherapy treatments on selfish de novo FGFR2 mutations in sperm of cancer survivors

Study question What effect does cancer treatment have on levels of spontaneous selfish fibroblast growth factor receptor 2 (FGFR2) point mutations in human sperm? Summary answer Chemotherapy an...

Full description

Bibliographic Details
Main Authors:	Maher, G, Bernkopf, M, Koelling, N, Wilkie, A, Meistrich, M, Goriely, A
Format:	Journal article
Published:	Oxford University Press 2019

Similar Items

Visualizing the origins of selfish de novo mutations in individual seminiferous tubules of human testes.
by: Maher, G, et al.
Published: (2016)

Contributions of intrinsic mutation rate and selfish selection to levels of de novo HRAS mutations in the paternal germline.
by: Giannoulatou, E, et al.
Published: (2013)

Missing heritability: paternal age effect mutations and selfish spermatogonia.
by: Goriely, A, et al.
Published: (2010)

Selfish mutations in Spermatogenesis and paternal age effects
by: Wilkie, A, et al.
Published: (2010)

Selfish mutations dysregulating RAS-MAPK signaling are pervasive in aged human testes
by: Maher, G, et al.
Published: (2018)

Personalized recurrence risk assessment following the birth of a child with a pathogenic de novo mutation
by: Bernkopf, M, et al.
Published: (2023)

Decoding germline de novo point mutations
by: Goriely, A
Published: (2016)

Cellular evidence for selfish spermatogonial selection in aged human testes
by: Maher, G, et al.
Published: (2014)

Cellular correlates of selfish spermatogonial selection
by: Maher, G, et al.
Published: (2016)

Paternal age effect mutations and selfish spermatogonial selection: causes and consequences for human disease.
by: Goriely, A, et al.
Published: (2012)

Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line.
by: Goriely, A, et al.
Published: (2003)

Paternal origin of FGFR3 mutations in Muenke-type craniosynostosis.
by: Rannan-Eliya, S, et al.
Published: (2004)

Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations.
by: Wilkie, A
Published: (2005)

Gain-of-function amino acid substitutions drive positive selection of FGFR2 mutations in human spermatogonia.
by: Goriely, A, et al.
Published: (2005)

Professionals’ views on providing personalized recurrence risks for de novo mutations: implications for genetic counseling
by: Kay, A, et al.
Published: (2024)

Professionals' views on providing personalized recurrence risks for de novo mutations: Implications for genetic counseling
by: Kay, AC, et al.
Published: (2024)

Origin of de novo KCNJ11 mutations and risk of neonatal diabetes for subsequent siblings.
by: Edghill, E, et al.
Published: (2007)

Selfish spermatogonial selection: evidence from an immunohistochemical screen in testes of elderly men
by: Lim, J, et al.
Published: (2012)

A further mutation of the FGFR2 tyrosine kinase domain in mild Crouzon syndrome.
by: de Ravel, T, et al.
Published: (2005)

Prevalence and architecture of de novo mutations in developmental disorders
by: Parker, M, et al.
Published: (2017)

amplimap: a versatile tool to process and analyze targeted NGS data
by: Koelling, N, et al.
Published: (2019)

Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors.
by: Goriely, A, et al.
Published: (2009)

Clinical hypochondroplasia in a family caused by a heterozygous double mutation in FGFR3 encoding GLY380LYS.
by: Santos, H, et al.
Published: (2007)

FGFR3 P250R mutation increases the risk of reoperation in apparent 'nonsyndromic' coronal craniosynostosis.
by: Thomas, G, et al.
Published: (2005)

Germline and somatic mosaicism for FGFR2 mutation in the mother of a child with Crouzon syndrome: Implications for genetic testing in "paternal age-effect" syndromes.
by: Goriely, A, et al.
Published: (2010)

Patterns of recurrence after definitive chemo-radiotherapy for oesophageal carcinoma
by: Button, MR, et al.
Published: (2007)

De novo mutations in EBF3 cause a neurodevelopmental syndrome
by: Sleven, H, et al.
Published: (2016)

Atypical Crouzon Syndrome With a Novel Cys62Arg Mutation in FGFR2 Presenting With Sagittal Synostosis.
by: Sharma, V, et al.
Published: (2012)

De novo point mutations in patients diagnosed with ataxic cerebral palsy
by: Parolin Schnekenberg, R, et al.
Published: (2015)

Differential regulation of FGFR3 controls FGFR1:FGFR3 balance in chondrocytes after cartilage injury
by: Khan, S, et al.
Published: (2016)

De novo mutations in GRIN1 cause extensive bilateral polymicrogyria
by: Fry, AE, et al.
Published: (2018)

Mild isolated craniosynostosis due to a novel FGFR3 mutation, p.Ala334Thr
by: Barroso, E, et al.
Published: (2011)

De novo truncating mutations in WASF1 cause intellectual disability with seizures
by: Ito, Y, et al.
Published: (2018)

Expression analysis of an FGFR2 IIIc 5' splice site mutation (1084+3A->G).
by: Kan, R, et al.
Published: (2004)

Mutational screening of FGFR1, CER1, and CDON in a large cohort of trigonocephalic patients.
by: Jehee, F, et al.
Published: (2006)

Selfish Reasons
by: Setiya, Kieran
Published: (2016)

Clinical and molecular consequences of disease-associated de novo mutations in SATB2
by: Bengani, H, et al.
Published: (2017)

"Selfish spermatogonial selection": a novel mechanism for the association between advanced paternal age and neurodevelopmental disorders.
by: Goriely, A, et al.
Published: (2013)

De novo and inherited loss-of-function variants in TLK2: clinical and genotype-phenotype evaluation of a distinct neurodevelopmental disorder
by: Reijnders, M, et al.
Published: (2018)

Fibroblast growth factor receptor 3 (FGFR3) mutation in a verrucous epidermal naevus associated with mild facial dysmorphism.
by: Collin, B, et al.
Published: (2007)